Abstract
Meta-analysis suggest that intracoronary (IC) administration of autologous bone marrow mononuclear cells (BMCs) delivered early after acute myocardial infarction (MI) may improve left ventricular (LV) function. However, many patients early post MI are unstable or present to sites without cell
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
